GLYC – glycomimetics, inc. (US:NASDAQ)
Stock Stats
News
Uproleselan's failed Phase III AML trial shakes up GlycoMimetics' future [Yahoo! Finance]
GlycoMimetics, Inc. (NASDAQ: GLYC) was downgraded by analysts at Capital One Financial Co. from an "overweight" rating to an "equal weight" rating.
GlycoMimetics reports data from Phase III AML treatment trial [Yahoo! Finance]
We're Keeping An Eye On GlycoMimetics' (NASDAQ:GLYC) Cash Burn Rate [Yahoo! Finance]
GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024
Form 10-Q GLYCOMIMETICS INC For: Mar 31
Form SC 13D/A GLYCOMIMETICS INC Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
Form 8-K GLYCOMIMETICS INC For: May 06
Form 8-K GLYCOMIMETICS INC For: May 01
Form 4 GLYCOMIMETICS INC For: May 01 Filed by: Koenig Scott
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.